CN115109091A - 基于苯频哪醇的具有开放侧向结构单元的双亚磷酸酯配体 - Google Patents

基于苯频哪醇的具有开放侧向结构单元的双亚磷酸酯配体 Download PDF

Info

Publication number
CN115109091A
CN115109091A CN202210270504.XA CN202210270504A CN115109091A CN 115109091 A CN115109091 A CN 115109091A CN 202210270504 A CN202210270504 A CN 202210270504A CN 115109091 A CN115109091 A CN 115109091A
Authority
CN
China
Prior art keywords
alkyl
butene
compound
compound according
tert
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210270504.XA
Other languages
English (en)
Inventor
A·C·萨勒
R·弗兰克
A·布拉彻
D·福里达格
A·马科维奇
P·库克米尔茨克
J·克诺萨亚
D·塞伦特
A·博尔纳
K·罗麦克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evonik Operations GmbH
Original Assignee
Evonik Operations GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Operations GmbH filed Critical Evonik Operations GmbH
Publication of CN115109091A publication Critical patent/CN115109091A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574Esters of oxyacids of phosphorus
    • C07F9/65746Esters of oxyacids of phosphorus the molecule containing more than one cyclic phosphorus atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/094Esters of phosphoric acids with arylalkanols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574Esters of oxyacids of phosphorus
    • C07F9/65742Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/18Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
    • B01J31/1845Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing phosphorus
    • B01J31/185Phosphites ((RO)3P), their isomeric phosphonates (R(RO)2P=O) and RO-substitution derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/49Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with carbon monoxide
    • C07C45/50Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with carbon monoxide by oxo-reactions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/49Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with carbon monoxide
    • C07C45/50Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with carbon monoxide by oxo-reactions
    • C07C45/505Asymmetric hydroformylation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/30Addition reactions at carbon centres, i.e. to either C-C or C-X multiple bonds
    • B01J2231/32Addition reactions to C=C or C-C triple bonds
    • B01J2231/321Hydroformylation, metalformylation, carbonylation or hydroaminomethylation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80Complexes comprising metals of Group VIII as the central metal
    • B01J2531/82Metals of the platinum group
    • B01J2531/822Rhodium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0073Rhodium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)

Abstract

本发明涉及基于苯频哪醇的具有开放侧向结构单元的双亚磷酸酯配体,和其在加氢甲酰化中的用途。

Description

基于苯频哪醇的具有开放侧向结构单元的双亚磷酸酯配体
本发明涉及基于苯频哪醇的具有开放侧向单元的双亚磷酸酯配体,和其在加氢甲酰化中的用途。
WO 2008/071508 A1中描述了使用双亚磷酸酯配体的加氢甲酰化方法。尤其描述了配体(D-1)的使用。
Figure BDA0003553084450000011
本发明解决的技术问题是提供与现有技术已知的化合物相比在烯烃的加氢甲酰化中提供增加的产率的新型化合物。
该问题通过根据权利要求1的化合物解决。
式(I)的化合物:
Figure BDA0003553084450000012
其中
R1、R2、R3、R4、R5、R6、R7、R8、R9、R10、R11、R12、R13、R14各自独立地选自-H、-(C1-C12)-烷基、-O-(C1-C12)-烷基、-(C4-C12)-芳基和基团R1、R2、R3、R4、R5以及基团R6、R7、R8、R9、R10可以彼此形成稠合体系。
因此,基团R1、R2、R3、R4、R5可通过一个环或多个环彼此连接,从而形成新的芳族体系。相应地,相同的情况也适用于基团R6、R7、R8、R9、R10。相反,例如,在基团R5和R6之间不可能形成稠合体系。基团R5和R6不位于相同的苯基上。
术语-(C1-C12)-烷基和-O-(C1-C12)-烷基包括具有1至12个碳原子的直链和支化的烷基。这些优选是-(C1-C8)-烷基或-O-(C1-C8)-烷基,特别优选-(C1-C4)-烷基或-O-(C1-C4)-烷基。
在一个实施方案中,R11和R14为-(C1-C12)-烷基。
在一个实施方案中,R11和R14为-tertBu。
在一个实施方案中,R12、R13选自-(C1-C12)-烷基、-O-(C1-C12)-烷基。
在一个实施方案中,R12和R13为-OCH3或-tertBu。
在一个实施方案中,R12和R13为-OCH3
在一个实施方案中,R1、R2、R3、R4、R5、R6、R7、R8、R9、R10选自-H、-(C1-C12)-烷基、-(C4-C12)-芳基。
在一个实施方案中,R1、R2、R3、R4、R5、R6、R7、R8、R9、R10选自-H、-tertBu、-(C4-C6)-芳基。
在一个实施方案中,该化合物具有结构(1)至(3)之一:
Figure BDA0003553084450000031
除了化合物本身之外,还要求保护其中使用该化合物的方法。
所述方法包含以下方法步骤:
a)预置入烯属不饱和化合物;
b)加入如上所述的化合物和包含Rh的物质;
c)供入H2和CO,
d)加热a)-c)的反应混合物,使烯属不饱和化合物转化为醛。
在该方法中,方法步骤a)、b)和c)可以以任何所需顺序进行。然而,通常在步骤a)和b)中已经预置入反应参与物之后加入CO。此外,CO也可以以多步供入,从而使得例如首先供入一部分CO,然后加热混合物,然后再供入另一部分CO。
在根据本发明方法中用作反应物的烯属不饱和化合物含有一个或多个碳-碳双键。为了简化,这些化合物在下文中也称为烯烃。双键可以是位于末端的或内部的。
在该方法的一个变体中,烯属不饱和化合物不包含除碳-碳双键之外的任何其它官能团。
在该方法的一个变体中,烯属不饱和化合物选自:乙烯、丙烯、1-丁烯、顺式和/或反式-2-丁烯、异丁烯、1,3-丁二烯、1-戊烯、顺式和/或反式-2-戊烯、2-甲基-1-丁烯、3-甲基-1-丁烯、2-甲基-2-丁烯、己烯、四甲基乙烯、庚烯、1-辛烯、2-辛烯、二正丁烯或其混合物。
在该方法的一个变体中,包含Rh的物质选自Rh(acac)(CO)2、[(acac)Rh(COD)](Umicore,acac=乙酰丙酮酸(Acetylacetonate)阴离子;COD=1,5-环辛二烯)、Rh4CO12
在该方法的一个变体中,在方法步骤c)中在1-6MPa(10-60巴)的压力下供入CO。
在该方法的一个变体中,在方法步骤d)中将反应混合物加热至80℃至160℃的温度。
下面将参照实施例更详细地说明本发明。
双(4-(叔丁基)苯基)(3,3'-二-叔丁基-5,5'-二甲氧基-2'-((4,4,5,5-四苯基- 1,3,2-二氧磷杂环戊烷-2-基)氧基)-[1,1'-联苯基]-2-基)亚磷酸酯(1)的合成:
Figure BDA0003553084450000041
在室温下,向2-((3,3'-二叔丁基-2'-((二氯膦基)氧基)-5,5'-二甲氧基-[1,1'-联苯基]-2-基)氧基)-4,4,5,5-四苯基-1,3,2-二氧磷杂环戊烷(0.7254g;0.8496mmol)在10ml甲苯中的溶液中滴加4-叔丁基苯酚(0.2808g;1.8691mmol)和三乙胺(2.39ml)在8ml甲苯中的混合物。搅拌过夜并过滤,将滤液减压浓缩至干。将得到的固体在60℃/0.1毫巴下干燥2小时。产率:0.869g(0.8036mmol,94%)。
元素分析(C68H74O8P2的计算值=1081.273g/mol):C=75.43(75.53);H=7.06(6.90);P=5.79(5.73)。
ESI-TOF HRMS:m/z=1103.4775;[M++Na],计算的m/z=1103.4756。
31P NMR(CD2Cl2):δ132.2(d,JPP=49Hz);145.3(d,JPP=49Hz)。
1H NMR(CD2Cl2):δ1.15(s,9H);1.33(s,9H);1.35(s,9H);1.53(s,9H);3.55(s,3H);3.76(s,3H);6.71-7.43(m,32H)ppm。
3,3'-二-叔丁基-5,5'-二甲氧基-2'-((4,4,5,5-四苯基-1,3,2-二氧磷杂环戊 烷-2-基)氧基)-[1,1'-联苯基]-2-基二(萘-1-基)亚磷酸酯(2)的合成:
Figure BDA0003553084450000051
在室温下,向2-((3,3'-二叔丁基-2'-((二氯膦基)氧基)-5,5'-二甲氧基-[1,1'-联苯基]-2-基)氧基)-4,4,5,5-四苯基-1,3,2-二氧磷杂环戊烷(0.5622g;0.6585mmol)在8ml甲苯中的溶液中滴加1-萘酚(0.2088g;1.4487mmol)和三乙胺(1.85ml)在6ml甲苯中的混合物。搅拌过夜并过滤,将滤液减压浓缩至干。将得到的固体在60℃/0.1毫巴下干燥2小时,然后容纳在6ml热乙腈中。将溶液在-29℃下储存后得到的固体分离,用很少量冷乙腈洗涤并干燥。产率:0.480g(0.449mmol,68%)。
元素分析(C68H62O8P2的计算值=1069.178g/mol):C=76.36(76.39);H=5.95(5.85);P=5.67(5.79)。
ESI-TOF HRMS:m/z=1091.3801;[M++Na],计算的m/z=1091.3817。
31P NMR(CD2Cl2):δ135.5(d,JPP=30Hz);146.2(d,JPP=30Hz)ppm。
1H NMR(CD2Cl2):δ1.14(s,9H);1.63(s,9H);2.94(s,3H);3.87(s,3H);6.33(d,4JHH=3.1Hz;1H);6.74(d,4JHH=3.1Hz;1H);6.89-7.84(m,35H);8.12(m,1H)ppm。
3,3'-二-叔丁基-5,5'-二甲氧基-2'-((4,4,5,5-四苯基-1,3,2-二氧磷杂环戊 烷-2-基)氧基)-[1,1'-联苯基]-2-基二(萘-2-基)亚磷酸酯(3)的合成:
Figure BDA0003553084450000061
在室温下,向2-((3,3'-二叔丁基-2'-((二氯膦基)氧基)-5,5'-二甲氧基-[1,1'-联苯基]-2-基)氧基)-4,4,5,5-四苯基-1,3,2-二氧磷杂环戊烷(0.5971g;0.6993mmol)在8ml甲苯中的溶液中滴加2-萘酚(0.2218g;1.5386mmol)和三乙胺(1.96ml)在6ml甲苯中的混合物。搅拌过夜并过滤,将滤液减压浓缩至干。将得到的固体在60℃/0.1毫巴下干燥2小时,然后容纳在6.5ml热乙腈中。将溶液在-29℃下储存后得到的固体分离,用很少量冷乙腈洗涤并干燥。产率:0.470g(0.439mmol,63%)。
元素分析(C68H62O8P2的计算值=1069.178g/mol):C=76.18(76.39);H=5.88(5.85);P=5.74(5.79)。
ESI-TOF HRMS:m/z=1091.3811;[M++Na],计算的m/z=1091.3817。
31P NMR(CD2Cl2):δ131.8(d,JPP=56Hz);145.0(d,JPP=56Hz)ppm。
1H NMR(CD2Cl2):δ1.15(s,9H);1.58(s,9H);3.48(s,3H);3.77(s,3H);6.78(m,1H);6.83(m,1H);6.86(m,1H);6.93-7.03(m,8H);7.07-7.23(m,11);7.35-7.52(m,10H);7.66(m,1H);7.72-7.85(m,5H)ppm。
催化实验
在Premex Reactor AG,Lengau(瑞士)公司的200ml高压釜中进行加氢甲酰化,该高压釜装配有保压阀、气体流量计、喷射搅拌器和压力吸管。为了使水分和氧气的影响最小化,使用作溶剂的甲苯在Pure Solv.MD-7系统中纯化并在氩气下储存。将用作底物的烯烃顺/反-2-戊烯(Aldrich)在钠上加热回流并在氩气下蒸馏。在氩气氛下,在高压釜中混合催化剂前体和配体的各自的甲苯溶液。将[(acac)Rh(COD)](Umicore,acac=乙酰丙酮酸阴离子;COD=1,5-环辛二烯)用作催化剂前体。在12巴下于搅拌(1500转/分)下加热高压釜,最终压力为20巴。在达到反应温度后,通过在压力吸管中调节得的正压将烯烃注入高压釜。反应在恒压(来自Bronkhorst(荷兰)公司的闭环压力调节器(Nachdruckregler))下进行4小时。在反应时间结束时,将高压釜冷却至室温,在搅拌的同时减压并用氩气吹扫。每种情形下在关闭搅拌器后立即取出1ml反应混合物,用10ml戊烷将其稀释并通过气相色谱分析:HP5890Series II plus,PONA,50m x 0.2mm x0.5μm。
使用根据本发明的化合物(1)至(3)和使用对比配体(D-1)进行反应。
Figure BDA0003553084450000071
反应条件:
烯烃:2-戊烯,溶剂:甲苯,铑的质量比例:100ppm,p:20巴,T:120℃,t:4h,Rh:配体比例=1:2。
结果汇编于下表中:
配体 醛的产率[%]
1* 46
2* 45
3* 50
D-1 14
*根据本发明的化合物
如实验结果所示,本发明的化合物解决了该问题。

Claims (13)

1.式(I)的化合物:
Figure FDA0003553084440000011
其中
R1、R2、R3、R4、R5、R6、R7、R8、R9、R10、R11、R12、R13、R14各自独立地选自-H、-(C1-C12)-烷基、-O-(C1-C12)-烷基、-(C4-C12)-芳基和基团R1、R2、R3、R4、R5以及基团R6、R7、R8、R9、R10可以彼此形成稠合体系。
2.根据权利要求1的化合物,
其中R11和R14为-(C1-C12)-烷基。
3.根据权利要求1和2任一项的化合物,
其中R11和R14为-tertBu。
4.根据权利要求1-3任一项的化合物,
其中R12、R13选自-(C1-C12)-烷基、-O-(C1-C12)-烷基。
5.根据权利要求1-4任一项的化合物,
其中R12和R13为-OCH3或-tertBu。
6.根据权利要求1-5任一项的化合物,
其中R1、R2、R3、R4、R5、R6、R7、R8、R9、R10选自-H、-(C1-C12)-烷基、-(C4-C12)-芳基。
7.根据权利要求1-8任一项的化合物,
其中R1、R2、R3、R4、R5、R6、R7、R8、R9、R10选自-H、-tertBu、-(C4-C6)-芳基。
8.根据权利要求1-7任一项的化合物,
其中该化合物具有结构(1)至(3)之一:
Figure FDA0003553084440000021
9.包含以下方法步骤的方法:
a)预置入烯属不饱和化合物;
b)加入根据权利要求1-8任一项的化合物和包含Rh的物质;
c)供入H2和CO,
d)加热a)至c)的反应混合物,使烯烃转化为醛。
10.根据权利要求9的方法,
其中方法步骤a)中的烯属不饱和化合物选自:乙烯、丙烯、1-丁烯、顺式和/或反式-2-丁烯、异丁烯、1,3-丁二烯、1-戊烯、顺式和/或反式-2-戊烯、2-甲基-1-丁烯、3-甲基-1-丁烯、2-甲基-2-丁烯、己烯、四甲基乙烯、庚烯、1-辛烯、2-辛烯、二正丁烯或其混合物。
11.根据权利要求9和10任一项的方法,
其中包含Rh的物质选自:Rh(acac)(CO)2、[(acac)Rh(COD)](Umicore,acac=乙酰丙酮酸阴离子;COD=1,5-环辛二烯)、Rh4CO12
12.根据权利要求9-11任一项的方法,
其中在方法步骤c)中在1-6MPa(10-60巴)范围的压力下供入CO。
13.根据权利要求9-12任一项的方法,
其中在方法步骤d)中将所述反应混合物加热至80℃至160℃的温度。
CN202210270504.XA 2021-03-18 2022-03-18 基于苯频哪醇的具有开放侧向结构单元的双亚磷酸酯配体 Pending CN115109091A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP21163482.9A EP4059918B1 (de) 2021-03-18 2021-03-18 Bisphosphitliganden auf basis von benzopinakol mit einem offenen flügelbaustein
EP21163482.9 2021-03-18

Publications (1)

Publication Number Publication Date
CN115109091A true CN115109091A (zh) 2022-09-27

Family

ID=75108246

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210270504.XA Pending CN115109091A (zh) 2021-03-18 2022-03-18 基于苯频哪醇的具有开放侧向结构单元的双亚磷酸酯配体

Country Status (6)

Country Link
US (1) US11739106B2 (zh)
EP (1) EP4059918B1 (zh)
JP (1) JP2022145577A (zh)
KR (1) KR20220130613A (zh)
CN (1) CN115109091A (zh)
ES (1) ES2965390T3 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4393588A1 (de) * 2022-12-27 2024-07-03 Evonik Oxeno GmbH & Co. KG Bisphosphite mit 2-naphthylresten

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10058383A1 (de) 2000-11-24 2002-05-29 Oxeno Olefinchemie Gmbh Neue Phosphininverbindungen und deren Metallkomplexe
DE102006058682A1 (de) 2006-12-13 2008-06-19 Evonik Oxeno Gmbh Bisphosphitliganden für die übergangsmetallkatalysierte Hydroformylierung
EP3029013B1 (de) 2014-12-04 2018-06-13 Evonik Degussa GmbH Monophosphite mit Struktureinheit 4,4,5,5-Tetraphenyl-1,3,2-dioxaphospholan als Liganden für Hydroformylierungskatalysatoren

Also Published As

Publication number Publication date
EP4059918A1 (de) 2022-09-21
ES2965390T3 (es) 2024-04-15
EP4059918B1 (de) 2023-10-11
JP2022145577A (ja) 2022-10-04
US11739106B2 (en) 2023-08-29
US20220298183A1 (en) 2022-09-22
KR20220130613A (ko) 2022-09-27

Similar Documents

Publication Publication Date Title
KR101918054B1 (ko) 합성 기체 분압의 조절에 의한 혼합된 리간드 하이드로폼일화 공정에서의 노말:아이소 알데하이드 비의 조절 방법
US20040054105A1 (en) Phosphorus-containing compositions and their use in hydrocyanation, isomerization and hydroformylation reactions
EP0888274B1 (en) Process to prepare a terminal aldehyde and catalyst
KR20010022368A (ko) 개선된 시안화수소 첨가 방법
CN115109091A (zh) 基于苯频哪醇的具有开放侧向结构单元的双亚磷酸酯配体
US5874641A (en) Process to prepare a terminal aldehyde
CN115109092A (zh) 基于苯频哪醇和1,3-丙二醇的双亚磷酸酯配体
US11667657B2 (en) Diphosphites based on cis-butene-1,4-diol
CN115109093A (zh) 基于亚膦酸酯-亚磷酸酯的配体
US11702435B2 (en) Bisphosphite ligands based on benzopinacol
JP3829346B2 (ja) 新規ビスホスファイトロジウム錯体及び該錯体を用いたアルデヒド類の製造方法
CN118255811A (zh) 具有2-萘基的二亚磷酸酯
US20240218001A1 (en) Diphosphites with substituents in the cis position
US20240218000A1 (en) Diphosphites with substituents in the trans position
US20240217998A1 (en) Diphosphites with a dicyclohexylphosphino radical
KR20240104017A (ko) 디시클로헥실포스피노 라디칼을 갖는 디포스파이트
CN118255810A (zh) 在反式位置具有取代基的二亚磷酸酯
CN118255813A (zh) 具有顺式位置的取代基的二亚磷酸酯
JP3928315B2 (ja) アルデヒドの製造方法
CN118255812A (zh) 具有二环己基膦基的二亚磷酸酯

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
TA01 Transfer of patent application right

Effective date of registration: 20231106

Address after: mAhR

Applicant after: Evonik Oxenor Co.,Ltd.

Address before: essen

Applicant before: Evonik Operations Ltd.

TA01 Transfer of patent application right
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination